5 completed. 5 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 5 |
| Phase 3 | 1 | Completed 1 |
Follow netupitant: new trials by email Literature Review of netupitant trials Research Report on netupitant
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of Olanzapine, Netupitant and Palonosetron in Controlling Nausea and Vomiting Associated With Highly Emetogenic Chemotherapy in Patients With Breast Cancer Olanzapine, Netupitant, Palonesetron - Nausea Post Chemotherapy | Phase 2 | Completed | Instituto Brasileiro de Controle do Cancer | 50 | 2020-12-17 | 2022-02-23 |
| PK/PD Study of Netupitant and Palonosetron in Pediatric Patients for Prevention of Chemotherapy-induced Nausea and Vomiting Netupitant, Palonosetron - Chemotherapy-induced Nausea and Vomiting (CINV) | Phase 2 | Completed | Helsinn Healthcare SA | 67 | 2017-08-31 | 2024-06-25 |
| Netupitant and Palonosetron Hydrochloride in Preventing Chronic Nausea and Vomiting in Patients With Cancer Netupitant, Palonosetron, Palonosetron Hydrochloride - Malignant Neoplasm, Nausea | Phase 2 / Phase 3 | Completed | M.D. Anderson Cancer Center | 53 | 2017-05-03 | 2023-10-17 |
| Netupitant and Palonosetron Hydrochloride in Preventing Chemotherapy Induced Nausea and Vomiting in Patients With Cancer Undergoing BEAM Conditioning Regimen Before Stem Cell Transplant Netupitant, Palonosetron Hydrochloride, Questionnaire Administration - Malignant Neoplasm | Phase 2 | Completed | OHSU Knight Cancer Institute | 43 | 2017-04-27 | 2021-07-12 |
| NEPA to Prevent Chemotherapy Induced Nausea and Vomiting in Patients With Breast Cancer Netupitant/Palonosetron - Chemotherapy-induced Nausea and Vomiting | Phase 2 | Completed | Consorzio Oncotech | 150 | 2016-05-12 | 2019-03-05 |
Nausea (3) · Vomiting (3) · Breast Neoplasms (2) · Neoplasms (2)
Consorzio Oncotech (1) · Helsinn Healthcare SA (1) · Instituto Brasileiro de Controle do Cancer (1) · M.D. Anderson Cancer Center (1) · OHSU Knight Cancer Institute (1)
United States (3) · Brazil (1) · Russia (1) · Serbia (1) · Ukraine (1)
David Hui (1) · Joseph Bubalo (1) · Michelino De Laurentiis, MD, PhD (1)